<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Geuka Africa | Lan Hansman | Activity</title>
	<link>https://geuka.org/members/lan4270835/activity/</link>
	<atom:link href="https://geuka.org/members/lan4270835/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Lan Hansman.</description>
	<lastBuildDate>Sat, 30 May 2026 14:54:09 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">cca7ca63faaaf984076b43d45ca8c6fd</guid>
				<title>Lan Hansman started the topic Clinical features associated with ADB-BUTINACA exposure in patients attending. in the forum Basic Home Budgeting</title>
				<link>https://geuka.org/forums/topic/clinical-features-associated-with-adb-butinaca-exposure-in-patients-attending-3/</link>
				<pubDate>Tue, 26 May 2026 07:59:43 +0000</pubDate>

									<content:encoded><![CDATA[<p>Taken together these data further confirmed the structure elucidation of B16. The precursor ion m/z 276 (B1) detected, which was 74 Da lower than that for the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicated N-dealkylation of B22. The precursor ion m/z 348 and product ion detected at m/z 217 (B2) identified was 2 Da less than the&hellip;<span class="activity-read-more" id="activity-read-more-204443"><a href="https://geuka.org/forums/topic/clinical-features-associated-with-adb-butinaca-exposure-in-patients-attending-3/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>